Correlation Between Kodiak Sciences and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kodiak Sciences and Structure Therapeutics American, you can compare the effects of market volatilities on Kodiak Sciences and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Structure Therapeutics.

Diversification Opportunities for Kodiak Sciences and Structure Therapeutics

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kodiak and Structure is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Kodiak Sciences and Structure Therapeutics

Considering the 90-day investment horizon Kodiak Sciences is expected to under-perform the Structure Therapeutics. In addition to that, Kodiak Sciences is 1.23 times more volatile than Structure Therapeutics American. It trades about -0.26 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.08 per unit of volatility. If you would invest  2,858  in Structure Therapeutics American on December 22, 2024 and sell it today you would lose (761.00) from holding Structure Therapeutics American or give up 26.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kodiak Sciences  vs.  Structure Therapeutics America

 Performance 
       Timeline  
Kodiak Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kodiak Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Structure Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Kodiak Sciences and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kodiak Sciences and Structure Therapeutics

The main advantage of trading using opposite Kodiak Sciences and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind Kodiak Sciences and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments